Related Experiment Video
Updated: Jun 17, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
The small GTPase activity of the ROC domain from LRRK2, a Parkinson's disease related protein
Qing-Shan Fu1, Ai-Xin Song, Su-Xia Li
1State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Abstract:
Mutations in the LRRK2 gene have been implicated in the pathogenesis of Parkinson's disease. This work provides biochemical evidence that the ROC domain of LRRK2 functions as a small GTPase, and the Parkinson's disease-associated mutants do not appear to have reduced GTP hydrolysis activities.
Insights
Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are linked to Parkinson's disease. This study shows the ROC domain of LRRK2 acts as a GTPase, with disease-associated mutants retaining GTP hydrolysis activity.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are a significant genetic factor in Parkinson's disease (PD) pathogenesis.
- Understanding the molecular mechanisms of LRRK2 is crucial for developing targeted therapies for PD.
Purpose of the Study:
- To biochemically characterize the function of the ROC domain of LRRK2.
- To investigate the GTPase activity of wild-type and Parkinson's disease-associated mutant forms of LRRK2.
Main Methods:
- Biochemical assays were employed to assess GTP binding and hydrolysis.
- Purified recombinant LRRK2 protein, including specific mutants associated with PD, was utilized.
Main Results:
- Biochemical evidence demonstrates that the ROC domain of LRRK2 functions as a small GTPase.
- Parkinson's disease-associated LRRK2 mutants exhibit comparable GTP hydrolysis activities to the wild-type protein, suggesting loss-of-function is not the primary mechanism for these mutants.
Conclusions:
- The ROC domain of LRRK2 possesses GTPase activity, consistent with its role in cellular signaling pathways relevant to Parkinson's disease.
- The findings challenge the notion that reduced GTP hydrolysis activity of LRRK2 mutants is the main driver of Parkinson's disease pathogenesis, opening new avenues for research.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins, also known...
GTPases and their Regulation
Large G-proteins, also known...
Activation and Inactivation of G Proteins
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
GPCRs Regulate Adenylyl Cylase Activity
Two...

